For what conditions is Lisinopril commonly indicated by the FDA?

Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor that is commonly indicated for several cardiovascular conditions. Its primary FDA-approved uses include the treatment of hypertension, which helps in lowering blood pressure and preventing complications such as stroke and heart attack. Additionally, Lisinopril is indicated for heart failure with reduced ejection fraction, as it helps improve symptoms and reduce mortality in these patients. It is also indicated in the management of ST-segment elevation myocardial infarction (MI), where it serves to improve survival by lowering blood pressure and decreasing the workload on the heart after a heart attack.

The other conditions listed do not align with the primary indications for Lisinopril. Stage fright and anxiety are typically treated with different classes of medications, primarily anxiolytics or beta-blockers, rather than an ACE inhibitor. Pulmonary hypertension is generally treated with medications specifically designed for vascular dilation in the pulmonary arterial system, unlike Lisinopril, which targets systemic blood pressure and heart failure management. Angina pectoris, while related to heart disease, is more commonly managed with medications like nitrates, beta-blockers, or calcium channel blockers rather than ACE inhibitors like Lisinopril. Hence, the combination of hypertension, heart failure